Clinical Trial

Unplanned Emergency Department Visits, Hospital Admission, or Death During Hospital-at-Home Care for Acute Infections

Completed
View on ClinicalTrials.gov →
Summary
This is a retrospective, multicenter, non-interventional cohort study based on data derived from existing electronic medical records. The study collects data on patient demographic and clinical characteristics, infection diagnosis, triage vital signs, laboratory values, and comorbidities in adults enrolled in the Emergency Department-initiated Hospital-at-Home (ED-HaH) model under Taiwan's National Health Insurance Administration (NHIA) Acute Care at Home (ACAH) Pilot Program. For patient selection, enrollment in the this pathway was used as the index event. All adult patients (aged ≥18 years) with a primary diagnosis of pneumonia, urinary tract infection (UTI), or skin and soft tissue infection (SSTI) - confirmed by ICD-10 codes - who were enrolled directly from the emergency department at one of three participating tertiary medical centers (Chi-Mei Medical Center, Wan-Fang Hospital, and Taipei Medical University Hospital) during August 1, 2024 to January 1, 2026 were considered for inclusion. Patients were identified through electronic medical record queries, and data were abstracted using a standardized case record form applied uniformly across all sites. The primary outcome was unplanned escalation or death during hospital-at-home (HaH), defined as unanticipated emergency department transfer, hospital admission, or intensive care unit admission, plus all-cause death prior to planned completion. As a secondary objective, exploratory multivariable analysis will examine whether demographic and clinical variables measured at ED enrollment show potential associations with this composite outcome. A total of 472 HaH episodes from 420 unique patients were analyzed. Statistical analyses will be performed for the overall cohort.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-07-14; most recent amendment 2026-07-21.
Trial Details
NCT Number NCT07703995
Lead Sponsor Chimei Medical Center
Collaborators: Taipei Medical University WanFang Hospital, Taipei Medical University Hospital
Conditions Hospital At Home, Emergency Service, Hospital, Acute Infection, Treatment Failure
Enrollment 447 participants
Start Date 2024-08-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-07-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-22